Monday, September 6, 2021

Covid: DCGI approves Hetero's Tocilizumab for hospitalised adults

Hetero, a globally renowned vertically integrated pharmaceutical organization, on Monday announced that the DCGI has issued EUA for the generic version of Tocilizumab in India

from Latest News https://ift.tt/3jODhr2
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

Related Posts:

0 comments: